Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case
The serum amyloid A (SAA) gene family is highly conserved and encodes acute phase proteins that are upregulated in response to inflammatory triggers. Over the years, a considerable amount of literature has been published attributing a wide range of biological effects to SAAs such as leukocyte recrui...
Saved in:
| Main Authors: | Sara Abouelasrar Salama, Mirre De Bondt, Nele Berghmans, Mieke Gouwy, Vivian Louise Soares de Oliveira, Sergio C. Oliveira, Flavio A. Amaral, Paul Proost, Jo Van Damme, Sofie Struyf, Mieke De Buck |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2020/6087109 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibiting CFTR through inh-172 in primary neutrophils reveals CFTR-specific functional defects
by: Ana Lúcia Da Silva Cunha, et al.
Published: (2024-12-01) -
Evaluation and Transformative Social Innovation: A Call for New Habits
by: Mieke Berghmans, et al.
Published: (2025-03-01) -
Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.
by: Rod Dawson, et al.
Published: (2009-09-01) -
IMMUNE DISTURBANCES IN PATIENTS WITH EPILEPSY AND OPPORTUNITY OF IMMUNOMODULATION BY RECOMBINANT HUMAN IL-2
by: L. V. Lipatova, et al.
Published: (2016-05-01) -
IMMUNOMODULATING THERAPY BY RECOMBINANT ALPHA-2B INTERFERON AMONG CHILDREN WITH TIMOMEGALIA
by: L.A. Nikulin, et al.
Published: (2007-08-01)